tiprankstipranks
Trending News
More News >
Amgen’s Strong Financial Performance and Promising Pipeline Drive Buy Rating
PremiumRatingsAmgen’s Strong Financial Performance and Promising Pipeline Drive Buy Rating
5d ago
Amgen reports Q1 adjusted EPS $4.90, consensus $4.26
Premium
The Fly
Amgen reports Q1 adjusted EPS $4.90, consensus $4.26
5d ago
Amgen backs FY25 adjusted EPS view $20.00-$21.20, consensus $20.63
Premium
The Fly
Amgen backs FY25 adjusted EPS view $20.00-$21.20, consensus $20.63
5d ago
Amgen assumed at Neutral from Overweight at Cantor Fitzgerald
PremiumThe FlyAmgen assumed at Neutral from Overweight at Cantor Fitzgerald
15d ago
Regeneron price target lowered to $850 from $1,152 at Canaccord
Premium
The Fly
Regeneron price target lowered to $850 from $1,152 at Canaccord
15d ago
Amgen assumed at Neutral from Overweight at Cantor Fitzgerald
Premium
The Fly
Amgen assumed at Neutral from Overweight at Cantor Fitzgerald
15d ago
Morning Movers: Pharmaceuticals sink as impending tariffs seen coming
PremiumThe FlyMorning Movers: Pharmaceuticals sink as impending tariffs seen coming
28d ago
Amgen price target raised to $330 from $328 at Morgan Stanley
Premium
The Fly
Amgen price target raised to $330 from $328 at Morgan Stanley
28d ago
Amgen announces FDA approval of Uplizna
Premium
The Fly
Amgen announces FDA approval of Uplizna
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100